Memotext

memotext-solid- resizable (1)

Media

MEMOTEXT Goes to the Canadian Psychiatric Association (CPA) Annual meeting in Vancouver, BC.

Posted on September 30, 2015 by Bill Simpson

As the Director of Scientific Development for MEMOTEXT I am honoured to have been invited to speak at this year’s Canadian Psychiatric Association (CPA) annual conference. The 2015 conference runs from Annual Conference October 1st – 3rd in Vancouver, British Columbia. I will be speaking at the “A clinician’s guide to mental health apps.” symposium on Thursday, October 1st at 10:15 PST. The focus of my contribution will be on mHealth and its capacity to affect positive behavioural change.

Read More »
30 September 2015

MEMOTEXT Founder and President Amos Adler to Present at Stanford Medicine X 2015

Abstract: “Using Disparate Data to Personalize Digital Health Behavior Change Interventions” to be presented at conference main stage

Toronto, ON September 16, 2015 – MEMOTEXT is pleased to announce that our Founder and President Amos Adler will be a main stage speaker at Stanford Medicine X 2015. Running from September 23-27 in the heart of Silicon Valley, Medicine X is a catalyst for sharing new ideas on the intersection of healthcare and emerging technologies. Hosted by Stanford University, Medicine X brings together both business and academia for a 4 day conversation on the future of healthcare.

Read More »
16 September 2015

The Meaning of “Meaningful Use”

How MEMOTEXT helps you achieve it

Posted on October 13, 2015 by Noah Nemoy

If you’re an American health care provider or are involved in digital health, odds are you’ve been hearing a lot about Meaningful Use (MU) Stage 3 in recent years. But what is it exactly? Why does it matter? And while we’re at it, what is MU Stages 1 and 2?

Read More »
1 September 2015

MEMOTEXT Publishes Whitepaper on Patient Adherence & Digital Health Interventions

“The MEMOTEXT Toolkit” walks readers through the problem of patient non-adherence, explaining the methodology behind our digital health interventions

Posted on July 23, 2015 by Noah Nemoy

MEMOTEXT is pleased to unveil “The MEMOTEXT Toolkit” Whitepaper. Authored by MEMOTEXT’s President and Founder Amos Adler M.Sc., Director of Scientific Development Bill Simpson P.hD(c) and Miki Peer P.hD(c), the document explains both the problem of patient adherence and outlines the science behind MEMOTEXT’s methodology.

Read More »
22 July 2015

We’re Going to Stanford!

MEMOTEXT Founder and President Amos Adler to Present at Stanford Medicine X 2015

Posted on July 23, 2015 by Noah Nemoy

MEMOTEXT is pleased to announce that our President and Founder Amos Adler will be speaking at Stanford Medicine X 2015! Running from September 23-27 in the heart of Silicon Valley, Medicine X is a catalyst for sharing new ideas on the intersection of healthcare and emerging technologies. Hosted by Stanford University, Medicine X brings together both business and academia for a 4 day conversation on the future of healthcare.

Read More »
22 July 2015

MEMOTEXT Makes the Top 20

MEMOTEXT is named by HIT Consultant as one of the Top 20 Canadian Digital Health Technology Start-Ups to Watch

Posted on July 23, 2015 by Noah Nemoy

Earlier this month HIT Consultant, released their list of the Top 20 Canadian digital health companies to lookout for. The companies on the list were selected for their potential for growth and represented disparate areas of digital health, including digital health solutions, diagnostics, and patient centred care. MEMOTEXT managed to not only make the Top 20, but was also one of the Top 10 digital health start-ups in Eastern Canada, and the only company of the 20 with an exclusive focus on patient adherence.

Read More »
22 July 2015

MEMOTEXT Pitches PAAS2015

Posted on July 6, 2015 by Noah Nemoy

Last week, MEMOTEXT Founder and President Amos Adler was invited to both attend and present at the 14th Annual Patient Adherence & Access Summit, or PAAS2015 in Philadelphia. While there MEMOTEXT had the opportunity to share in the discussion of the latest issues regarding patient adherence and access, to medication.

Read More »
6 July 2015

MEMOTEXT Presents at the Pittsburgh Science of Medication Adherence:

Director of Scientific Development Bill Simpson unveils our new BAM adherence metric

Posted on June 26, 2015 by Bill Simpson

2 weeks ago MEMOTEXT had the privilege of presenting our new Balanced Adherence Metric (BAM) at the inaugural Science of Medication Adherence Conference (SMA2015), hosted by the University of Pittsburgh Centre for Pharmaceutical Policy and Prescribing.

Read More »
26 June 2015

MEMOTEXT and PerformRx Co-Present HealthNHand’s PBM and Health Plan Enrolled- Asthma Patient Adherence Case Study

Posted on June 17, 2015 by Noah Nemoy

On Monday morning, MEMOTEXT’s Founder and President Amos Adler and PerformRx’s Director of Drug Therapy Management Programs & Outcomes Lauren C. Megargell, had the honor to jointly present the results of our HealthNHandSM asthma adherence program to the The Digital Transformation of Patient Care: New Avenues for Pharma Growth Seminar. The seminar was organized by the Consulate General of Canada in New York’s Canadian Technology Accelerator (CTA) Health IT Philadelphia as part of BIO2015.

Read More »
17 June 2015

Wow #HealthDataPalooza That Was Awesome!

Posted on June 09, 2015 by Amos Adler

We’ve just got back from the awesomeness that was Health Datapalooza 2015! Where to start? #HDP was 3 days of some of the most enthusiastic and exciting health data conversations we’ve had in years. With D.C.’s Marriott Wardman Park packed with digital health nerds, it was almost non-stop presentations, demonstrations and general health data game-on.

Read More »
9 June 2015

MEMOTEXT Corp. Validating New Adherence Metric: The Balanced Adherence Metric (BAM)

MEMOTEXT to present at both Washington D.C.’s Health Datapalooza 2015 and Pittsburgh’s SMA 2015 this week

Washington, D.C. June 1, 2015 – MEMOTEXT Corp. announces today the upcoming presentation of the Balanced Adherence Metric (BAM). The BAM will be presented tomorrow by MEMOTEXT’s Director of Scientific Development Bill Simpson, Ph.D. Candidate in Neuroscience, at the inaugural Science of Medication Adherence conference (SMA 2015) at the University of Pittsburgh. MEMOTEXT also has a delegation at Washington D.C.’s Health Datapalooza 2015 including Founder and President of MEMOTEXT Amos Adler, M.Sc. Health Datapalooza 2015 runs from today until Wednesday and MEMOTEXT will be present for the entire duration.

Read More »
1 June 2015

MEMOTEXT Goes to Washington: We’ll be at Health Datapalooza 2015 at Booth 315, cupcakes and all

Posted on May 28, 2015 by Noah Nemoy

Next week marks the start of one of the biggest and most exciting events in the digital and mHealth space: Health Datapalooza 2015. Health Datapalooza was launched in 2010, as a multidisciplinary forum on how to best utilize health data and information technology. But as the importance of Digital and mHealth ballooned over the past 5 years, so has Health Datapalooza. This year, 2,400 people are expected to attend the 4 day showcase of the latest in healthcare technology innovation.

Read More »
28 May 2015

We use cookies to ensure you get the best experience on our website. By continuing to browse this website, you accept the use of the cookies for the stated purpose. Learn more by reading our privacy policy.

Got It

Join the MEMOTEXT Mailing List!

Get updates on new products, projects and stay on top of all things MEMOTEXT.